Artal Group S.A. Axcella Health Inc. Transaction History

Artal Group S.A.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$4.12 - $5.91 $772,500 - $1.11 Million	-187,500 Reduced 20.83%	712,500 $3.29 Million
Q2 2020 Aug 14, 2020	BUY	$2.94 - $7.7 $882,000 - $2.31 Million	300,000 Added 50.0%	900,000 $4.98 Million
Q1 2020 May 14, 2020	BUY	$2.25 - $5.24 $337,500 - $786,000	150,000 Added 33.33%	600,000 $2.05 Million
Q3 2019 Nov 14, 2019	BUY	$5.25 - $9.26 $316,359 - $557,998	60,259 Added 15.46%	450,000 $2.55 Million
Q2 2019 Aug 09, 2019	BUY	$8.51 - $14.95 $3.32 Million - $5.83 Million	389,741 New	389,741 $3.63 Million

61.6K

Ticker AXLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,500,896
Description
Axcella Health Inc. operates as a clinical stage biotechnology company in the United States. The company treats complex diseases and enhances health using endogenous metabolic modulator compositions. Its lead product candidates include AXA1665, which is in Phase 2 clinical trial for the reduction in risk of overt hepatic encephalopathy recurrenc...

Get notified when there are updates to the investment portfolio of Artal Group S.A., based on Form 13F filings with the SEC.

Stay updated on Artal Group S.A. with notifications on news.